Richard K: Primary prevention of coronary heart disease. Drug Des Devel Ther. 2011, 5: 325-380.
Google Scholar
Richard K: Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention. Ther Adv Cardiovasc Dis. 2011, 5: 61-81. 10.1177/1753944710391350.
Article
Google Scholar
Muniyappa R, Montagnani M, Koh KK, Quon MJ: Cardiovascular actions of insulin. Endocr Rev. 2007, 28: 463-491. 10.1210/er.2007-0006.
Article
CAS
PubMed
Google Scholar
Reaven GM: Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. Panminerva Med. 2005, 47: 201-210.
CAS
PubMed
Google Scholar
Kim JA, Montagnani M, Koh KK, Quon MJ: Reciprocal relationships between insulin resistance and endothelial dysfunction molecular and pathophysiological mechanisms. Circulation. 2006, 113: 1888-1904. 10.1161/CIRCULATIONAHA.105.563213.
Article
PubMed
Google Scholar
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and h-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.
Article
CAS
PubMed
Google Scholar
Nishio K, Fukui T, Tsunoda F, Kawamura K, Itoh S, Konno N, Ozawa K, Katagiri T: Insulin resistance as a predictor for restenosis after coronary stenting. Int J Cardiol. 2005, 103: 128-134. 10.1016/j.ijcard.2004.08.039.
Article
PubMed
Google Scholar
Song A, Xu M, Bi Y, Xu Y, Huang Y, Li M, Wang T, Wu Y, Liu Y, Li X, Chen Y, Wang W, Ning G: Serum fetuin-A associated with type 2 diabetes and insulin resistance in Chinese adults. PLoS One. 2011, 6: e19228-10.1371/journal.pone.0019228.
Article
PubMed Central
CAS
PubMed
Google Scholar
Cirillo M: Evaluation of glomerular filtration rate and of albuminuria/proteinuria. J Nephrol. 2010, 23: 125-132.
CAS
PubMed
Google Scholar
Gensini GG: A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983, 51: 606-10.1016/S0002-9149(83)80105-2.
Article
CAS
PubMed
Google Scholar
Liang KW, Lee WJ, Lee WL, Chen YT, Ting CT, Sheu WH: Diabetes exacerbates angiographic coronary lesion progression in subjects with metabolic syndrome independent of CRP levels. Clin Chim Acta. 2008, 388: 41-45. 10.1016/j.cca.2007.10.003.
Article
CAS
PubMed
Google Scholar
Kuan HL, The LL, Li CH, Hwu CM: Clinical and biochemical indicators of homeostasis model assessment-estimated insulin resistance in postmenopausal women. J Chin Med Assoc. 2011, 74: 442-447. 10.1016/j.jcma.2011.08.014.
Article
Google Scholar
Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Cacciatori V, Santi L, Targher G, Bonadonna R, Muggeo M: HOMA-Estimated Insulin Resistance Is an Independent Predictor of Cardiovascular Disease in Type 2 Diabetic Subjects, Prospective data from the Verona Diabetes Complications Study. Diabetes Care. 2002, 25: 1135-1141. 10.2337/diacare.25.7.1135.
Article
PubMed
Google Scholar
Muniyappa R, Iantorno M, Quon MJ: An Integrated View of Insulin Resistance and Endothelial Dysfunction. Endocrinol Metab Clin North Am. 2008, 37: 685-711. 10.1016/j.ecl.2008.06.001.
Article
PubMed Central
CAS
PubMed
Google Scholar
Deepa R, Velmurugan K, Arvind K, Sivaram P, Sientay C, Uday S, Mohan V: Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance—the Chennai Urban Rural Epidemiology Study (CURES). Metabolism. 2006, 55: 1232-1238. 10.1016/j.metabol.2006.05.008.
Article
CAS
PubMed
Google Scholar
Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996, 334: 952-957. 10.1056/NEJM199604113341504.
Article
CAS
PubMed
Google Scholar
Amano T, Matsubara T, Uetani T, Nanki M, Marui N, Kato M, Yoshida T, Arai K, Yokoi K, Ando H, Kumagai S, Ishii H, Izawa H, Hotta N, Murohara T: Abnormal glucose regulation is associated with lipid-rich coronary plaque: relationship to insulin resistance. JACC Cardiovasc Imaging. 2008, 1: 39-45. 10.1016/j.jcmg.2007.09.003.
Article
PubMed
Google Scholar
Marso SP, House JA, Hopkins PJ: Increase in interleukin-6 following arterial injury is related to insulin resistance, the −174 G → C polymorphism and complex plaque morphology. Int J Immunogenet. 2006, 33: 347-354. 10.1111/j.1744-313X.2006.00622.x.
Article
CAS
PubMed
Google Scholar
Broedl UC, Lebherz C, Lehrke M, Stark R, Greif M, Becker A, von Ziegler F, Tittus J, Reiser M, Becker C, Göke B, Parhofer KG, Leber AW: Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques. PLoS One. 2009, 4: e4733-10.1371/journal.pone.0004733.
Article
PubMed Central
PubMed
Google Scholar
Nissen SE, Nicholls SJ, Wolski K, Nesto R, Kupfer S, Perez A, Jure H, De Larochellière R, Staniloae CS, Mavromatis K, Saw J, Hu B, Lincoff AM, Tuzcu EM: Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes, The PERISCOPE randomized controlled trial. JAMA. 2008, 299: 1561-1573. 10.1001/jama.299.13.1561.
Article
CAS
PubMed
Google Scholar
Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF, Kent KM, Griffin J, Leon MB: Patterns and mechanism of in-stent restenosis, A serial intravascular ultrasound study. Circulation. 1996, 94: 1247-1254. 10.1161/01.CIR.94.6.1247.
Article
CAS
PubMed
Google Scholar
Kim MS, Dean LS: Review: In-Stent Restenosis. Cardiovasc Ther. 2011, 29: 190-198. 10.1111/j.1755-5922.2010.00155.x.
Article
PubMed
Google Scholar
Nathan DM, Balkau B, Bonora E: The International Expert Committee: International Expert Committee Report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009, 32: 1327-1334.
Article
CAS
Google Scholar
Martins RA, Jones JG, Cumming SP, Silva MJ Coelho e, Teixeira AM, Veríssimo MT: Glycated hemoglobin and associated risk factors in older adults. Cardiovasc Diabetol. 2012, 11: 13-10.1186/1475-2840-11-13.
Article
PubMed Central
CAS
PubMed
Google Scholar
Liu Y, Yang YM, Zhu J, Tan HQ, Liang Y, Li JD: Prognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease, A systematic review and meta-analysis. Cardiovasc Diabetol. 2011, 10: 98-10.1186/1475-2840-10-98.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ueda H, Mitsusada N, Harimoto K, Miyawaki M, Yasuga Y, Hiraoka H: Glycosylated hemoglobin is a predictor of major adverse cardiac events after drug-eluting stent implantation in patients with diabetes mellitus. Cardiology. 2010, 116: 51-57. 10.1159/000314331.
Article
CAS
PubMed
Google Scholar
Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A, Day N: Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ. 2001, 322: 15-18. 10.1136/bmj.322.7277.15.
Article
PubMed Central
CAS
PubMed
Google Scholar
Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N: Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med. 2004, 141: 413-420.
Article
CAS
PubMed
Google Scholar
Gerstein HC, Swedberg K, Carlsson J, CHARM Program Investigators: The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Arch Intern Med. 2008, 168: 1699-1704. 10.1001/archinte.168.15.1699.
Article
CAS
PubMed
Google Scholar
Unwin N, Shaw J, Zimmet P, Alberti KG: Impaired fasting glycemia: the current definition and intervention. Diabet Med. 2002, 19: 708-723.
Article
CAS
PubMed
Google Scholar
Esteghamati A, Ashraf H, Khalilzadeh O, Zandieh A, Nakhjavani M, Rashidi A, Haghazali M, Asgari F: Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutr Metab (Lond). 2010, 7: 26-10.1186/1743-7075-7-26.
Article
Google Scholar